[Federal Register Volume 76, Number 66 (Wednesday, April 6, 2011)]
[Pages 19101-19102]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-8146]



Health Resources and Services Administration

Advisory Council on Blood Stem Cell Transplantation; Notice of 

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 

[[Page 19102]]

    Name: Advisory Council on Blood Stem Cell Transplantation.
    Date and Times: May 11, 2011, 8 a.m. to 4:30 p.m.
    Place: Georgetown University Hotel and Conference Center, 3800 
Reservoir Road, NW., Washington, DC 20057.
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section 
379 of the Public Health Service Act, as amended), the Advisory Council 
on Blood Stem Cell Transplantation (ACBSCT) advises the Secretary of 
HHS and the Administrator, HRSA, on matters related to the activities 
of the C.W. Bill Young Cell Transplantation Program (Program) and the 
National Cord Blood Inventory (NCBI) Program.
    Agenda: The Council will hear reports from five ACBSCT Work Groups: 
Cord Blood Bank Collections, Realizing the Potential of Cord Blood, 
Scientific Factors Necessary to Define a Cord Blood Unit as High 
Quality, Cord Blood Thawing and Washing, and Access to Transplantation. 
The Council also will hear presentations and discussions on the 
following topics: Current State of Knowledge-Cord Blood 
Transplantation; National Marrow Donor Program (NMDP) Analysis of 
National Cord Blood Inventory (NCBI) and Non-NCBI Cord Blood Units; 
Adverse Event Reporting; Cord Blood Studies at the National Institutes 
of Health; and Report on NMDP Cord Blood Financial Summit. Agenda items 
are subject to change as priorities indicate.
    After the presentations and Council discussions, members of the 
public will have an opportunity to provide comments. Because of the 
Council's full agenda and the timeframe in which to cover the agenda 
topics, public comment will be limited. All public comments will be 
included in the record of the ACBSCT meeting. Meeting summary notes 
will be made available on the HRSA's Program Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html.
    Those planning to attend are requested to register in advance and 
those wishing to make oral comments should so indicate. The draft 
meeting agenda and a registration form are available on the HRSA's 
Program Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html.
    Registration also can be completed electronically at http://www.acbsct.com or submitted by facsimile to Lux Consulting Group, Inc., 
the logistical support contractor for the meeting, at fax number (301) 
585-7741 ATTN: Deborah Jones. Individuals without access to the 
Internet who wish to register may call Deborah Jones at (301) 585-1261.

FOR FURTHER INFORMATION CONTACT: Patricia Stroup, Executive Secretary, 
Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Room 12C-06, Rockville, Maryland 
20857; telephone (301) 443-1127.

    Dated: March 29, 2011.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2011-8146 Filed 4-5-11; 8:45 am]